Literature DB >> 14670933

Hyperlipidemia promotes osteoclastic potential of bone marrow cells ex vivo.

Yin Tintut1, Sean Morony, Linda L Demer.   

Abstract

OBJECTIVE: Osteoporosis is associated epidemiologically with atherosclerosis and hyperlipidemia. We previously found that atherogenic lipids regulate bone formation. To determine whether hyperlipidemia also affects bone resorption, we compared osteoclastogenesis in marrow preosteoclasts derived from hyperlipidemic versus control mice.
METHODS: Nonadherent marrow cells from low-density lipoprotein receptor-/- (LDLR-/-)and C57BL/6J mice were cultured with M-CSF and ligand for receptor activator of nuclear factor-kappaB (RANKL). Functional osteoclastic activity, measured as number of resorption pits, was significantly greater in 12-month-old LDLR-/-. Similar results were obtained in 5- and 10-month-old LDLR-/- versus C57BL/6J mice on a high-fat diet. Osteoclastic differentiation, indicated by tartrate resistant acid phosphatase (TRAP) activity, was significantly greater in the 12-month-old LDLR-/-, and there was a trend toward increased TRAP activity in LDLR-/- on a high-fat diet, at ages 5 and 10 months. Osteoclastic parameters correlated with total serum lipoproteins with a possible threshold effect. Osteoporotic human cortical bone stained positive for lipids in the perivascular space of Haversian canals by oil red O. The presence of lipid hydroperoxides was detected in bone marrow from hyperlipidemic mice.
CONCLUSIONS: Hyperlipidemia may contribute to osteoporosis via increased osteoclastic bone resorption.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14670933     DOI: 10.1161/01.ATV.0000112023.62695.7f

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  74 in total

1.  Cholesterol in vascular and valvular calcification.

Authors:  L L Demer
Journal:  Circulation       Date:  2001-10-16       Impact factor: 29.690

2.  QCT Volumetric Bone Mineral Density and Vascular and Valvular Calcification: The Framingham Study.

Authors:  Jimmy J Chan; L Adrienne Cupples; Douglas P Kiel; Christopher J O'Donnell; Udo Hoffmann; Elizabeth J Samelson
Journal:  J Bone Miner Res       Date:  2015-05-06       Impact factor: 6.741

3.  New Clues that May Link Osteoporosis to the Circulating Lipid Profile.

Authors:  Catalina Poiana; Valentin Radoi; Mara Carsote; John P Bilezikian
Journal:  Bone Res       Date:  2013-09-25       Impact factor: 13.567

4.  Blood and interstitial flow in the hierarchical pore space architecture of bone tissue.

Authors:  Stephen C Cowin; Luis Cardoso
Journal:  J Biomech       Date:  2014-12-31       Impact factor: 2.712

5.  The Quest for Osteoporosis Mechanisms and Rational Therapies: How Far We've Come, How Much Further We Need to Go.

Authors:  Stavros C Manolagas
Journal:  J Bone Miner Res       Date:  2018-02-22       Impact factor: 6.741

Review 6.  Metabolic reprogramming in osteoclasts.

Authors:  Kyung-Hyun Park-Min
Journal:  Semin Immunopathol       Date:  2019-09-24       Impact factor: 9.623

7.  Quantitative trait loci for BMD in an SM/J by NZB/BlNJ intercross population and identification of Trps1 as a probable candidate gene.

Authors:  Naoki Ishimori; Ioannis M Stylianou; Ron Korstanje; Michael A Marion; Renhua Li; Leah Rae Donahue; Clifford J Rosen; Wesley G Beamer; Beverly Paigen; Gary A Churchill
Journal:  J Bone Miner Res       Date:  2008-09       Impact factor: 6.741

Review 8.  Vascular calcification: pathobiology of a multifaceted disease.

Authors:  Linda L Demer; Yin Tintut
Journal:  Circulation       Date:  2008-06-03       Impact factor: 29.690

9.  Regulation of interleukin-6 expression in osteoblasts by oxidized phospholipids.

Authors:  Wendy Tseng; Jinxiu Lu; Gail A Bishop; Andrew D Watson; Andrew P Sage; Linda Demer; Yin Tintut
Journal:  J Lipid Res       Date:  2009-11-11       Impact factor: 5.922

10.  The association between bone mineral density and metabolic syndrome: a Korean population-based study.

Authors:  Hoon Kim; Han Jin Oh; Hoon Choi; Woong Hwan Choi; Sung-Kil Lim; Jung Gu Kim
Journal:  J Bone Miner Metab       Date:  2013-03-26       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.